Ann: Elixinol Global raises A$40m to accelerate international gro, page-78

medical cannabis has been legal in australia since october 2016

there are maybe 1500 patients currently approved

this is a tiny business, a total distraction for the company that can go on and be one of top global hemp names

if they get manufacture license they would still need export license and then fin legal markets (US for instance canot be exported to as DEA is fedral and controls customs)

there are also existing companies such as MDC with product and export license and many many global competitors

In my view it is a distraction and EX should focus on Hemp / ireespective of the supposed basis of the IPO to raie money for MC development

THE KEY ISSUE HERE IS COMPANIES NEED TO BE DYNAMIC, change staregy if nescessary to make most of opportunity as it emerges and clearly that is now US HEMP